Rankings
▼
Calendar
AMRN Q2 2017 Earnings — Amarin Corporation plc Revenue & Financial Results | Market Cap Arena
AMRN
Amarin Corporation plc
$335M
Q2 2017 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$45M
+36.6% YoY
Gross Profit
$34M
74.8% margin
Operating Income
-$11M
-25.2% margin
Net Income
-$14M
-30.1% margin
EPS (Diluted)
$-1.01
QoQ Revenue Growth
+30.6%
Cash Flow
Operating Cash Flow
-$11M
Free Cash Flow
-$11M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$170M
Total Liabilities
$209M
Stockholders' Equity
-$39M
Cash & Equivalents
$85M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$45M
$33M
+36.6%
Gross Profit
$34M
$24M
+39.5%
Operating Income
-$11M
-$14M
+20.8%
Net Income
-$14M
-$13M
-2.1%
← FY 2017
All Quarters
Q3 2017 →